logo for Bioatla

Bioatla Employee Directory

Bioatla corporate office is located in 11085 Torreyana Rd, San Diego, California, 92121, United States and has 53 employees.

Bioatla Global Presence

globalPresence illustration
LocationPeople at location
North America58

Search All Employees

Bioatla CEO

Jay ShortBioatla
Jay ShortChairman, Chief Executive Officer & Co-Founder
PhonePhoneEmailEmail
See Profile

Key Employees of Bioatla

Search Full List of Executives

Index of contact profiles from Bioatla

1-25 of 53 results
Contact Name
Contact Info
Job Title
Location
Last Update
1 2 3 right

Frequently Asked Questions regarding Bioatla Employees

How many employees does Bioatla have?
Bioatla has 53 employees
Who is the CEO of Bioatla?
Bioatla’s CEO is Jay Short
Who is the CFO of Bioatla?
Bioatla’s CFO is Richard Waldron
Who are Bioatla key employees?
Some of Bioatla key employees are Richard Waldron
Where is Bioatla located?
Bioatla’s headquarters are located at 11085 Torreyana Rd, San Diego, California, 92121, United States
How do I contact Bioatla?
Bioatla Contact Info: Phone number: (858) 558-0708 Website: www.bioatla.com
What does Bioatla do?

BioAtla is a global clinical-stage biotechnology company with operations in San Diego, California, and in Beijing, China through our contractual relationship with BioDuro-Sundia, a provider of preclinical development services. Utilizing its proprietary Conditionally Active Biologics (CAB) technology, BioAtla develops novel, reversibly active monocl... onal antibody and other protein therapeutic product candidates. CAB product candidates are designed to have more selective targeting, greater efficacy with lower toxicity, and more cost-efficient and predictable manufacturing than traditional antibodies. BioAtla has extensive and worldwide patent coverage for its CAB technology and products with more than 500 patents, more than 250 of which are issued. Broad patent coverage in all major markets include methods of making, screening and manufacturing CAB product candidates in a wide range of formats and composition of matter coverage for specific products. BioAtla has two first-in-class CAB programs currently in Phase 2 clinical testing in the United States, mecbotamab vedotin, BA3011, a novel conditionally active AXL-targeted antibody-drug conjugate (CAB-AXL-ADC), and ozuriftamab vedotin, BA3021, a novel conditionally active ROR2-targeted antibody-drug conjugate (CAB-ROR2-ADC).Read More

Is Bioatla a public company?
Yes, Bioatla is a public company and is traded under the symbol BCAB
See more information about Bioatla Employees

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.